Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: Contemporary experience from a single institution

Lung Cancer

Volumn 49, Issue 2, 2005, Pages 209-215

  Giordano, Karin F ^a   Jatoi, Aminah ^a   Adjei, Alex A ^a   Creagan, Edward T ^a   Croghan, Gary ^a   Frytak, Stephen ^a   Jett, James R ^a   Marks, Randolph ^a   Molina, Julian ^a   Okuno, Scott ^a   Richardson, Ronald L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bilirubin; Creatinine; Lung cancer; Organ dysfunction; Renal insufficiency; Small cell; Thrombocytopenia

Indexed keywords

ANTINEOPLASTIC AGENT; BILIRUBIN; CARBOPLATIN; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; ETOPOSIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DECISION MAKING; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HOSPITAL CARE; HUMAN; LUNG SMALL CELL CANCER; MALE; MEDICAL RECORD; METABOLIC ACIDOSIS; MONOTHERAPY; MULTIPLE ORGAN FAILURE; NEUTROPENIA; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT OUTCOME; URINARY TRACT INFECTION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIRUBIN; CARBOPLATIN; CARCINOMA, SMALL CELL; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; DECISION MAKING; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDICAL RECORDS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEOPLASM STAGING; PACLITAXEL; PLATELET COUNT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 22044450043     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.01.009     Document Type: Article

References (14)

1. R.A. Green, E. Humphrey, H. Close, and M.E. Patno Alkylating agents in bronchogenic carcinoma Am J Med 46 1969 516 525
2. D.H. Johnson, J.D. Hainsworth, and F.A. Greco Extrahepatic biliary obstruction caused by small cell lung cancer Ann Intern Med 102 1985 487 490
3. P. Patel, L.L. Henry, A.K. Ganti, and A. Potti Clinical course of lung cancer in patients with chronic kidney disease Lung Cancer 43 2004 297 300
4. B.J. Roth, D.H. Johnson, L.H. Einhorn, L.P. Schater, N.C. Cherng, and H.J. Cohen Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of the two regimens in extensive small cell lung cancer: a phase III trial from the Southeastern Cancer Study Group J Clin Oncol 10 1992 282 291
5. M. Fukuoka, K. Furuse, N. Saijo, Y. Nishiwaki, H. Ikegami, and T. Tamura Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small cell lung cancer J Natl Cancer Inst 83 1991 855 861
6. S.A. Laurie, D. Logan, B.R. Markman, J.A. Mackay, and W.K. Evans Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small cell lung cancer Lung Cancer 43 2004 223 240
7. http://wwwmicromed.mayo.edu.
8. S.G. Arbuck, H.O. Douglass, W.R. Crom, P. Goodwin, Y. Silk, and C. Cooper Etoposide pharmacokinetics in patients with normal and abnormal organ function J Clin Oncol 4 1986 1690 1695
9. K. Noda, Y. Nishiwaki, M. Kawahara, S. Negoro, T. Sngiura, and A. Yokoyama Irinotecan plus cisoplatin compared with etoposide plus cisplatin for extensive small cell lung cancer N Engl J Med 346 2002 85 91
10. A.T. Turrisi, K. Kim, R. Blum, W.T. Sause, R.B. Livingston, and R. Komaki Twice-daily compared to once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide N Engl J Med 340 1999 265 271
11. P.J. Woll, N. Thatcher, L. Lomax, J. Hodgetts, S.M. Lee, and P.A. Burt Use of hematopoietic progenitors in whole blood to support dose dense chemotherapy: a randomized phase II trial in small cell lung cancer patients J Clin Oncol 19 2001 712 719
12. G. Williams, R. Pazdur, and R. Temple Assessing tumor-related signs and symptoms to support cancer drug approval J Biopharm Stat 14 2004 5 21
13. The American Society of Clinical Oncology Outcomes of cancer treatment for technology assessment and cancer treatment guidelines J Clin Oncol 14 1996 671 679
14. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, vol. 92. National Cancer Institute of the United States, National Cancer Institute of Canada; 2000. p. 205-16.